Stay updated on HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial
Sign up to get notified when there's something new on the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page.

Latest updates to the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.6.4 now appears on the page, replacing the previous v3.6.3. This denotes a minor update to the ClinicalTrials.gov interface and does not modify the study content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe page's revision indicator was updated from v3.6.2 to v3.6.3, indicating a minor update to the study record.SummaryDifference0.1%

- Check31 days agoChange DetectedPage revision label updated from v3.6.0 to v3.6.2, indicating a new revision of the page content. This appears to be a minor maintenance update and does not modify study data or user-facing information.SummaryDifference0.1%

- Check38 days agoChange DetectedPublications section added to the study record with a PubMed citation related to the HSV-2 vaccine research. It also notes that publications are auto-filled from PubMed and may not all pertain directly to the study.SummaryDifference0.3%

- Check45 days agoChange DetectedNew recruitment status indicates enrollment is closed; new user guidance sections were added, the Intervention/Treatment header formatting was adjusted, and the revision label updated to v3.6.0.SummaryDifference0.5%

- Check52 days agoChange DetectedThe page revision label has been updated to `v3.5.5`, replacing the previous `v3.5.4`. This reflects a minor page build/update.SummaryDifference0.1%

Stay in the know with updates to HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page.